Podcast from Opportunities in Proton Therapy: Head and Neck

Abramson Cancer Center of the University of Pennsylvania
Last Modified: April 24, 2007

Share article


OncoLink Podcast

Subscribe to OncoLink Podcasts Subscribe to OncoLink Podcasts on iTunes

You may also use Quicktime to view the individual presentation:

Head and Neck
Robert Malyapa, M.D., Assistant Professor, Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, FL

iTunes Manual Instructions:

  1. Click Advanced
  2. Subscribe to Podcast
  3. Add URL http://tv.oncolink.org/Podcasts/podcasts.xml


News
AACR: New Drug May Add to Therapy for Head and Neck CA

Sep 19, 2014 - The investigational drug alpelisib (previously known as BYL719) appears to inhibit activation of the pathway that leads to resistance to cetuximab, an anti-epidermal growth factor receptor agent used in the treatment of head and neck cancer. These findings were presented at the American Association for Cancer Research's special conference "Targeting the PI3K-mTOR Network in Cancer," held from Sept. 14 to 17 in Philadelphia.



OncoLink Treatment Binder

Select the side effects and forms for your patient's treatment binder

Learn More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More